Top Tweets for #ccc19
Waging War on War Metaphors in Cancer and COVID-19 [Jul 31, 2020] @JonMarronMD @drdonsdizon @BanuSymington @mtmdphd @AbbyRosenbergMD @JCOOP_ASCO https://t.co/G15N92bF8l #CoronaHeroes #COVID19nCancer #COVID19 #scicomm #CCC19 cc @COVID19nCCC
![mtmdphd's tweet photo. Waging War on War Metaphors in Cancer and COVID-19 [Jul 31, 2020] @JonMarronMD @drdonsdizon @BanuSymington @mtmdphd @AbbyRosenbergMD @JCOOP_ASCO https://t.co/G15N92bF8l #CoronaHeroes #COVID19nCancer #COVID19 #scicomm #CCC19 cc @COVID19nCCC https://t.co/1btQTIpWQB](https://pbs.twimg.com/media/HI7y5n5XIAAnY3p.jpg)
COVID-19 in Patients With Gynecologic Cancer: A Report From the COVID-19 and Cancer Consortium [Mar 16, 2026] @AlainaJBrown et al. @COVID19nCCC @JCOOA_ASCO https://t.co/lZU3hFiNSS #gyncsm #CCC19 #COVID19nCancer #COVID19
![mtmdphd's tweet photo. COVID-19 in Patients With Gynecologic Cancer: A Report From the COVID-19 and Cancer Consortium [Mar 16, 2026] @AlainaJBrown et al. @COVID19nCCC @JCOOA_ASCO https://t.co/lZU3hFiNSS #gyncsm #CCC19 #COVID19nCancer #COVID19 https://t.co/mG18P0SHk3](https://pbs.twimg.com/media/HFEd1wMaIAAvWmd.png)
Association of Clinical Factors & Recent Anti-Cancer Therapy with COVID-19 Severity among Patients with Cancer: A Report from the COVID-19 and Cancer Consortium [3/18/21] @PGrivasMDPhD @arkhaki et al. @COVID19nCCC @Annals_Oncology https://t.co/WH5PPJySj6 #CCC19 #COVID19nCancer
![mtmdphd's tweet photo. Association of Clinical Factors & Recent Anti-Cancer Therapy with COVID-19 Severity among Patients with Cancer: A Report from the COVID-19 and Cancer Consortium [3/18/21] @PGrivasMDPhD @arkhaki et al. @COVID19nCCC @Annals_Oncology https://t.co/WH5PPJySj6 #CCC19 #COVID19nCancer https://t.co/WN6maEUppn](https://pbs.twimg.com/media/HFEcR9UWoAAgtWj.jpg)
![mtmdphd's tweet photo. Association of Clinical Factors & Recent Anti-Cancer Therapy with COVID-19 Severity among Patients with Cancer: A Report from the COVID-19 and Cancer Consortium [3/18/21] @PGrivasMDPhD @arkhaki et al. @COVID19nCCC @Annals_Oncology https://t.co/WH5PPJySj6 #CCC19 #COVID19nCancer https://t.co/WN6maEUppn](https://pbs.twimg.com/media/HFEcQvqW4AA8kms.jpg)
Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a #CCC19 registry analysis [Mar 9, 2022] @rubinstein_md et al. @mtmdphd @COVID19nCCC @BCD_AACR https://t.co/IMEbvgZI4Q #COVID19nCancer #COVID19 #bmtsm #leusm #lymsm #mmsm #mpnsm
![mtmdphd's tweet photo. Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a #CCC19 registry analysis [Mar 9, 2022] @rubinstein_md et al. @mtmdphd @COVID19nCCC @BCD_AACR https://t.co/IMEbvgZI4Q #COVID19nCancer #COVID19 #bmtsm #leusm #lymsm #mmsm #mpnsm https://t.co/3qQxnrPDcZ](https://pbs.twimg.com/media/G8T2DK-W0AIyPct.jpg)
Convalescent Plasma and Survival in Hematologic Malignancy and COVID-19 [Jun 17, 2021] @mtmdphd & @DrJPHenderson et al. @jwsenefeld @DrDimpyShah @hemoncwarner @COVID19nCCC - @JAMAOnc https://t.co/g3GP7Ets4q #COVID19CP #CCC19 #COVID19nCancer #COVID19 #IDonc
![mtmdphd's tweet photo. Convalescent Plasma and Survival in Hematologic Malignancy and COVID-19 [Jun 17, 2021] @mtmdphd & @DrJPHenderson et al. @jwsenefeld @DrDimpyShah @hemoncwarner @COVID19nCCC - @JAMAOnc https://t.co/g3GP7Ets4q #COVID19CP #CCC19 #COVID19nCancer #COVID19 #IDonc https://t.co/BzmYiTEGVH](https://pbs.twimg.com/media/G8T0rDBWsAQ-hQY.jpg)
Convalescent Plasma and Survival in Hematologic Malignancy and COVID-19 [Jun 17, 2021] @mtmdphd & @DrJPHenderson et al. @jwsenefeld @DrDimpyShah @hemoncwarner @COVID19nCCC - @JAMAOnc https://t.co/g3GP7Ets4q #COVID19CP #CCC19 #COVID19nCancer #COVID19 #IDonc
![mtmdphd's tweet photo. Convalescent Plasma and Survival in Hematologic Malignancy and COVID-19 [Jun 17, 2021] @mtmdphd & @DrJPHenderson et al. @jwsenefeld @DrDimpyShah @hemoncwarner @COVID19nCCC - @JAMAOnc https://t.co/g3GP7Ets4q #COVID19CP #CCC19 #COVID19nCancer #COVID19 #IDonc https://t.co/uLDsfzZg4G](https://pbs.twimg.com/media/G5lfFYjXYAA_mjN.jpg)
Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a #CCC19 registry analysis [Mar 9, 2022] @rubinstein_md et al. @mtmdphd @COVID19nCCC @BCD_AACR https://t.co/IMEbvgZI4Q #COVID19nCancer #COVID19 #bmtsm #leusm #lymsm #mmsm #mpnsm
![mtmdphd's tweet photo. Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a #CCC19 registry analysis [Mar 9, 2022] @rubinstein_md et al. @mtmdphd @COVID19nCCC @BCD_AACR https://t.co/IMEbvgZI4Q #COVID19nCancer #COVID19 #bmtsm #leusm #lymsm #mmsm #mpnsm https://t.co/vMgDxsvaAf](https://pbs.twimg.com/media/G5lerGDWcAAdutb.png)
![mtmdphd's tweet photo. Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a #CCC19 registry analysis [Mar 9, 2022] @rubinstein_md et al. @mtmdphd @COVID19nCCC @BCD_AACR https://t.co/IMEbvgZI4Q #COVID19nCancer #COVID19 #bmtsm #leusm #lymsm #mmsm #mpnsm https://t.co/vMgDxsvaAf](https://pbs.twimg.com/media/G5leo3KXIAAvFhs.jpg)
![mtmdphd's tweet photo. Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a #CCC19 registry analysis [Mar 9, 2022] @rubinstein_md et al. @mtmdphd @COVID19nCCC @BCD_AACR https://t.co/IMEbvgZI4Q #COVID19nCancer #COVID19 #bmtsm #leusm #lymsm #mmsm #mpnsm https://t.co/vMgDxsvaAf](https://pbs.twimg.com/media/G5lemDNXAAAYSxH.jpg)
Time-Related Biases in Nonrandomized COVID-19βEra Studies Using Real-world Data [Jun 17, 2021] @gregcalip @RMiksad Sarkar @JAMAOnc https://t.co/lXZTYLYL5t #COVID19CP #COVID19nCancer #COVID19 #CCC19 @COVID19nCCC ...real-world data should continue to play a crucial role...
![mtmdphd's tweet photo. Time-Related Biases in Nonrandomized COVID-19βEra Studies Using Real-world Data [Jun 17, 2021] @gregcalip @RMiksad Sarkar @JAMAOnc https://t.co/lXZTYLYL5t #COVID19CP #COVID19nCancer #COVID19 #CCC19 @COVID19nCCC ...real-world data should continue to play a crucial role... https://t.co/olKErYeGMD](https://pbs.twimg.com/media/G5QHy4JXcAAuNox.jpg)
![mtmdphd's tweet photo. Time-Related Biases in Nonrandomized COVID-19βEra Studies Using Real-world Data [Jun 17, 2021] @gregcalip @RMiksad Sarkar @JAMAOnc https://t.co/lXZTYLYL5t #COVID19CP #COVID19nCancer #COVID19 #CCC19 @COVID19nCCC ...real-world data should continue to play a crucial role... https://t.co/olKErYeGMD](https://pbs.twimg.com/media/G5QHx0QW0AEpx9T.png)
![mtmdphd's tweet photo. Time-Related Biases in Nonrandomized COVID-19βEra Studies Using Real-world Data [Jun 17, 2021] @gregcalip @RMiksad Sarkar @JAMAOnc https://t.co/lXZTYLYL5t #COVID19CP #COVID19nCancer #COVID19 #CCC19 @COVID19nCCC ...real-world data should continue to play a crucial role... https://t.co/olKErYeGMD](https://pbs.twimg.com/media/G5QHwxXWMAA0PXk.jpg)
![mtmdphd's tweet photo. Time-Related Biases in Nonrandomized COVID-19βEra Studies Using Real-world Data [Jun 17, 2021] @gregcalip @RMiksad Sarkar @JAMAOnc https://t.co/lXZTYLYL5t #COVID19CP #COVID19nCancer #COVID19 #CCC19 @COVID19nCCC ...real-world data should continue to play a crucial role... https://t.co/olKErYeGMD](https://pbs.twimg.com/media/G5QHvyzXgAAhiq3.png)
Convalescent Plasma and Survival in Hematologic Malignancy and COVID-19 [Jun 17, 2021] @mtmdphd & @DrJPHenderson et al. @jwsenefeld @DrDimpyShah @hemoncwarner @COVID19nCCC - @JAMAOnc https://t.co/g3GP7EsUeS #COVID19CP #CCC19 #COVID19nCancer #COVID19 #IDonc
![mtmdphd's tweet photo. Convalescent Plasma and Survival in Hematologic Malignancy and COVID-19 [Jun 17, 2021] @mtmdphd & @DrJPHenderson et al. @jwsenefeld @DrDimpyShah @hemoncwarner @COVID19nCCC - @JAMAOnc https://t.co/g3GP7EsUeS #COVID19CP #CCC19 #COVID19nCancer #COVID19 #IDonc https://t.co/lyXE4zOly6](https://pbs.twimg.com/media/G5QHs3EWEAAqryZ.jpg)
Convalescent Plasma and Survival in Hematologic Malignancy and COVID-19 [Jun 17, 2021] @mtmdphd & @DrJPHenderson et al. @jwsenefeld @DrDimpyShah @hemoncwarner @COVID19nCCC - @JAMAOnc https://t.co/g3GP7EsUeS #COVID19CP #CCC19 #COVID19nCancer #COVID19 #IDonc
![mtmdphd's tweet photo. Convalescent Plasma and Survival in Hematologic Malignancy and COVID-19 [Jun 17, 2021] @mtmdphd & @DrJPHenderson et al. @jwsenefeld @DrDimpyShah @hemoncwarner @COVID19nCCC - @JAMAOnc https://t.co/g3GP7EsUeS #COVID19CP #CCC19 #COVID19nCancer #COVID19 #IDonc https://t.co/NsYaPxWYwP](https://pbs.twimg.com/media/G5FHwOIWsAAuWL7.jpg)
Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a #CCC19 registry analysis [Mar 9, 2022] @rubinstein_md et al. @mtmdphd @COVID19nCCC @BCD_AACR https://t.co/IMEbvgZafi #COVID19nCancer #COVID19 #bmtsm #leusm #lymsm #mmsm #mpnsm
![mtmdphd's tweet photo. Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a #CCC19 registry analysis [Mar 9, 2022] @rubinstein_md et al. @mtmdphd @COVID19nCCC @BCD_AACR https://t.co/IMEbvgZafi #COVID19nCancer #COVID19 #bmtsm #leusm #lymsm #mmsm #mpnsm https://t.co/ANAtFuOOIx](https://pbs.twimg.com/media/G5FHqevWoAAD2c7.jpg)
Convalescent Plasma and Survival in Hematologic Malignancy and COVID-19 [Jun 17, 2021] @mtmdphd & @DrJPHenderson et al. @jwsenefeld @DrDimpyShah @hemoncwarner @COVID19nCCC - @JAMAOnc https://t.co/g3GP7Ets4q #COVID19CP #CCC19 #COVID19nCancer #COVID19 #IDonc
![mtmdphd's tweet photo. Convalescent Plasma and Survival in Hematologic Malignancy and COVID-19 [Jun 17, 2021] @mtmdphd & @DrJPHenderson et al. @jwsenefeld @DrDimpyShah @hemoncwarner @COVID19nCCC - @JAMAOnc https://t.co/g3GP7Ets4q #COVID19CP #CCC19 #COVID19nCancer #COVID19 #IDonc https://t.co/ni26FxKd02](https://pbs.twimg.com/media/G2lPCk7XoAAyqMP.jpg)
Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer [Mar 28, 2022] Fu et al. @DrDimpyShah @COVID19nCCC @JAMANetworkOpen https://t.co/8OldndLrR8 #NCT04354701 #cancerdisparities #CCC19 #COVID19nCancer #COVID19
![mtmdphd's tweet photo. Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer [Mar 28, 2022] Fu et al. @DrDimpyShah @COVID19nCCC @JAMANetworkOpen https://t.co/8OldndLrR8 #NCT04354701 #cancerdisparities #CCC19 #COVID19nCancer #COVID19 https://t.co/TpxPVFjZ0w](https://pbs.twimg.com/media/G1sR77SX0AAujKK.png)
COVID-19 and cancer: A review of the registry-based pandemic response [Sep 2, 2021] @ADesaiMD @DrTJM_MD et al. @JAMAOnc https://t.co/98nOR8p3sq #COVID19nCancer #CCC19 @COVID19nCCC
![mtmdphd's tweet photo. COVID-19 and cancer: A review of the registry-based pandemic response [Sep 2, 2021] @ADesaiMD @DrTJM_MD et al. @JAMAOnc https://t.co/98nOR8p3sq #COVID19nCancer #CCC19 @COVID19nCCC https://t.co/UFFNDCy5VQ](https://pbs.twimg.com/media/G1sRZ0LW0AAnTTE.png)
Crowdsourcing a crisis response for COVID-19 in oncology [Apr 21, 2020] @ADesaiMD @hemoncwarner @NicoleKuderer @mtmdphd @corrie_painter @gary_lyman @GlopesMd @NatureCancer https://t.co/u71snM4dRd #CCC19 #COVID19nCANCER @COVID19nCCC
![mtmdphd's tweet photo. Crowdsourcing a crisis response for COVID-19 in oncology [Apr 21, 2020] @ADesaiMD @hemoncwarner @NicoleKuderer @mtmdphd @corrie_painter @gary_lyman @GlopesMd @NatureCancer https://t.co/u71snM4dRd #CCC19 #COVID19nCANCER @COVID19nCCC https://t.co/i50ZZy63aV](https://pbs.twimg.com/media/G1sRVgAWcAAHysv.png)
Association of Clinical Factors & Recent Anti-Cancer Therapy with COVID-19 Severity among Patients with Cancer: A Report from the COVID-19 and Cancer Consortium [3/18/21] @PGrivasMDPhD @arkhaki et al. @COVID19nCCC @Annals_Oncology https://t.co/WH5PPJzq8E #CCC19 #COVID19nCancer
![mtmdphd's tweet photo. Association of Clinical Factors & Recent Anti-Cancer Therapy with COVID-19 Severity among Patients with Cancer: A Report from the COVID-19 and Cancer Consortium [3/18/21] @PGrivasMDPhD @arkhaki et al. @COVID19nCCC @Annals_Oncology https://t.co/WH5PPJzq8E #CCC19 #COVID19nCancer https://t.co/H5qVWoE3MR](https://pbs.twimg.com/media/G1sRPFWWwAAuFpy.jpg)
![mtmdphd's tweet photo. Association of Clinical Factors & Recent Anti-Cancer Therapy with COVID-19 Severity among Patients with Cancer: A Report from the COVID-19 and Cancer Consortium [3/18/21] @PGrivasMDPhD @arkhaki et al. @COVID19nCCC @Annals_Oncology https://t.co/WH5PPJzq8E #CCC19 #COVID19nCancer https://t.co/H5qVWoE3MR](https://pbs.twimg.com/media/G1sROKXXYAAEbzi.jpg)
Utilization of #COVID19 Tx & clinical outcomes among Pts w/ cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort study [Jul 22, 2020] @DrDonnaRivera et al @CD_AACR https://t.co/enSLlL3rF1 #AACRCovid #COVID19nCancer Fig2 Heatmap of selected clinical fx stratified by Tx exposures
![mtmdphd's tweet photo. Utilization of #COVID19 Tx & clinical outcomes among Pts w/ cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort study [Jul 22, 2020] @DrDonnaRivera et al @CD_AACR https://t.co/enSLlL3rF1 #AACRCovid #COVID19nCancer Fig2 Heatmap of selected clinical fx stratified by Tx exposures https://t.co/RjyIcrqesl](https://pbs.twimg.com/media/G1sQ0usXoAAj_jE.jpg)
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study [May 28, 2020] @NicoleKuderer @DrChoueiri et al. @brian_rini @hemoncwarner @TheLancet https://t.co/fITWCzwMaS #NCT04354701 #CCC19 #COVID19nCancer #COVID19 https://t.co/T8p0qwyStZ @COVID19nCCC
![mtmdphd's tweet photo. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study [May 28, 2020] @NicoleKuderer @DrChoueiri et al. @brian_rini @hemoncwarner @TheLancet https://t.co/fITWCzwMaS #NCT04354701 #CCC19 #COVID19nCancer #COVID19 https://t.co/T8p0qwyStZ @COVID19nCCC https://t.co/lOTg0AWyVL](https://pbs.twimg.com/media/G1sQp9qWAAAUqv4.jpg)
Convalescent Plasma and Survival in Hematologic Malignancy and COVID-19 [Jun 17, 2021] @mtmdphd & @DrJPHenderson et al. @jwsenefeld @DrDimpyShah @hemoncwarner @COVID19nCCC - @JAMAOnc https://t.co/g3GP7Ets4q #COVID19CP #CCC19 #COVID19nCancer #COVID19 #IDonc
![mtmdphd's tweet photo. Convalescent Plasma and Survival in Hematologic Malignancy and COVID-19 [Jun 17, 2021] @mtmdphd & @DrJPHenderson et al. @jwsenefeld @DrDimpyShah @hemoncwarner @COVID19nCCC - @JAMAOnc https://t.co/g3GP7Ets4q #COVID19CP #CCC19 #COVID19nCancer #COVID19 #IDonc https://t.co/F6MrWz1GB8](https://pbs.twimg.com/media/G1sQh54WQAA4mYz.jpg)
Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a #CCC19 registry analysis [Mar 9, 2022] @rubinstein_md et al. @mtmdphd @COVID19nCCC @BCD_AACR https://t.co/IMEbvgZI4Q #COVID19nCancer #COVID19 #bmtsm #leusm #lymsm #mmsm #mpnsm
![mtmdphd's tweet photo. Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a #CCC19 registry analysis [Mar 9, 2022] @rubinstein_md et al. @mtmdphd @COVID19nCCC @BCD_AACR https://t.co/IMEbvgZI4Q #COVID19nCancer #COVID19 #bmtsm #leusm #lymsm #mmsm #mpnsm https://t.co/Zrbcr5G8sK](https://pbs.twimg.com/media/G1sQdWSW0AAYLx1.jpg)
Last Seen Hashtags on Sotwe
ΰΈΰΈ±ΰΈΰΈ§ΰΉΰΈ²ΰΈ§ΰΉΰΈΰΈ§ΰΉΰΈΰΈ§ΰΈ’
Seen from Thailand
HibtGainers
Ψ΄Ω
ΩΩ
Seen from Turkey
NoLimits #nsfw
Seen from Egypt
Monaco
Seen from France
PowerBottom
Seen from United States
sacramento
Seen from United States
ixlii
Seen from United States
Spideypool
Seen from Mexico
secretfilmed
Seen from United States
Most Popular Users
Elon Musk 
@elonmusk
240.6M followers
Barack Obama
@barackobama
119.2M followers
Donald J. Trump
@realdonaldtrump
111.7M followers
Cristiano Ronaldo
@cristiano
110.5M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.6M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
90.9M followers
KATY PERRY
@katyperry
87.6M followers
Taylor Swift
@taylorswift13
81.5M followers
Lady Gaga
@ladygaga
73M followers
Virat Kohli
@imvkohli
69.8M followers
Kim Kardashian
@kimkardashian
69.8M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
63.9M followers
Neymar Jr
@neymarjr
62.6M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.9M followers
X
@x
60.8M followers
Selena Gomez
@selenagomez
60.7M followers